FDA OKs EarlySense monitoring device

11/20/2007 | Globes (Israel)

The FDA has granted Israel-based EarlySense Ltd. approval for its EverOn system, a heart and lung monitor that uses a proprietary contact-free sensor to reduce patient discomfort and enable monitoring at home and at hospitals. The system, which is being tested on patients with chronic diseases, is expected to be available next year.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC